<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39185269</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-7076</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>IJID regions</Title><ISOAbbreviation>IJID Reg</ISOAbbreviation></Journal><ArticleTitle>Menopause symptom prevalence in three post-COVID-19 syndrome clinics in England: A cross-sectional analysis.</ArticleTitle><Pagination><StartPage>100405</StartPage><MedlinePgn>100405</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100405</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijregi.2024.100405</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">There is an overlap between symptoms of perimenopause/menopause and post-COVID syndrome and there is a concern that some female patients referred to post-COVID syndrome clinics may have undiagnosed perimenopause/menopause. However, the prevalence of such symptoms in this population is unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Cross-sectional analysis of 122 women's health questionnaires as part of a service improvement project in three National Health Service post-COVID syndrome clinics in England. The primary outcomes were prevalence of menopause symptoms and association between the total menopause symptom questionnaire (MSQ) score and the key predictors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Age group 40-54 years showed the highest prevalence of most individual symptoms and the highest mean total MSQ score (36.4; confidence interval [CI] 32.3-40.6), correlating clinically with the onset of perimenopause/menopause. Regression modeling shows a significant positive parabolic relationship between age and total MSQ score. Age group 40-54 years is associated with a 6.60-point higher (CI 1.31-11.9) total MSQ score than the age group 55-79 years; an increase of one index of multiple deprivation quintile is associated with a 2.85-point lower (CI -1.24 to -4.45) total MSQ score; presence of a gynecologic diagnosis is associated with a 6.31-point higher (CI 1.32-11.3) total MSQ score. A total of 51% of patients who menstruate reported menstrual disturbance with COVID-19 infection and 21% with COVID-19 vaccination.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Symptoms possibly attributable to perimenopause and menopause were highly prevalent among female patients attending post-COVID syndrome clinics in Greater Manchester, England. Our findings provide key prevalence estimates and significant predictors of MSQ scores that are vital for future research, clinical practice, and policy.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Donal O'Donoghue Renal Research Centre, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Primary Care &amp; Health Services Research, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rochdale Care Organisation, Northern Care Alliance NHS Foundation Trust, Rochdale, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heald</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medical Sciences, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pyne</LastName><ForeName>Yvette</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakerly</LastName><ForeName>Nawar Diar</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, Manchester Metropolitan University, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>IJID Reg</MedlineTA><NlmUniqueID>9918418183106676</NlmUniqueID><ISSNLinking>2772-7076</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Menopause</Keyword><Keyword MajorTopicYN="N">Perimenopause</Keyword><Keyword MajorTopicYN="N">Population health</Keyword><Keyword MajorTopicYN="N">Women's Health</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>5</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39185269</ArticleId><ArticleId IdType="pmc">PMC11342884</ArticleId><ArticleId IdType="doi">10.1016/j.ijregi.2024.100405</ArticleId><ArticleId IdType="pii">S2772-7076(24)00076-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3) doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison CJ, Davies B, Cooper E, Lound A, Whitaker M, Hampshire A, et al. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat Commun. 2023;14(1) doi: 10.1038/s41467-023-41879-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-41879-2</ArticleId><ArticleId IdType="pmc">PMC10598213</ArticleId><ArticleId IdType="pubmed">37875536</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Chen G, Hou H, Liao Q, Chen J, Bai H, et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod Biomed Online. 2021;42:260&#x2013;267. doi: 10.1016/j.rbmo.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7522626</ArticleId><ArticleId IdType="pubmed">33288478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp GC, Fraser A, Sawyer G, Kountourides G, Easey KE, Ford G, et al. The COVID-19 pandemic and the menstrual cycle: research gaps and opportunities. Int J Epidemiol. 2022;51:691&#x2013;700. doi: 10.1093/ije/dyab239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab239</ArticleId><ArticleId IdType="pmc">PMC8690231</ArticleId><ArticleId IdType="pubmed">34865021</ArticleId></ArticleIdList></Reference><Reference><Citation>Baena-Garc&#xed;a L, Aparicio VA, Molina-L&#xf3;pez A, Aranda P, C&#xe1;mara-Roca L, Oc&#xf3;n-Hern&#xe1;ndez O. Premenstrual and menstrual changes reported after COVID-19 vaccination: the EVA project. Womens Health (Lond) 2022;18 doi: 10.1177/17455057221112237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17455057221112237</ArticleId><ArticleId IdType="pmc">PMC9289916</ArticleId><ArticleId IdType="pubmed">35833668</ArticleId></ArticleIdList></Reference><Reference><Citation>balance. &#x2018;Menopause Symptom Questionnaire&#x2019;, balance menopause, https://www.balance-menopause.com/menopause-library/menopause-symptom-sheet/; 2021 [accessed 19 November 2023].</Citation></Reference><Reference><Citation>balance. &#x2018;Menopause App Treatment Pathway&#x2019;, balance menopause, https://www.balance-menopause.com/balance-for-hcp/; 2021 [accessed 19 November 2023].</Citation></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk - a signal to address sex hormones and women's health. Lancet Reg Health Eur. 2021;11 doi: 10.1016/j.lanepe.2021.100242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Diabetes Endocrinology Menopause: a turning point for women's health. Lancet Diabetes Endocrinol. 2022;10:373. doi: 10.1016/S2213-8587(22)00142-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00142-5</ArticleId><ArticleId IdType="pubmed">35526555</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Research Authority . 2024. Is my study research? Decision Tool.</Citation></Reference><Reference><Citation>ORCHA. ORCHA: balance menopause support, https://appfinder.orcha.co.uk/defaultsearch/?search=balance; 2023 [accessed 19 November 2023].</Citation></Reference><Reference><Citation>Greene JG. Constructing a standard climacteric scale. 1998. 10.1016/s0378-5122(98)00025-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0378-5122(98)00025-5</ArticleId><ArticleId IdType="pubmed">9643514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Housing, Communities and Local Government. English indices of deprivation 2019: postcode lookup, https://imd-by-postcode.opendatacommunities.org/imd/2019; 2019 [accessed 27 November 2023].</Citation></Reference><Reference><Citation>Mishra GD, Davies MC, Hillman S, Chung HF, Roy S, Maclaran K, et al. Optimising health after early menopause. Lancet. 2024;403:958&#x2013;968. doi: 10.1016/S0140-6736(23)02800-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)02800-3</ArticleId><ArticleId IdType="pubmed">38458215</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Menopause, https://www.who.int/news-room/fact-sheets/detail/menopause; 2022 [accessed 12 March 2024].</Citation></Reference><Reference><Citation>Thakur M, Kaur M, Sinha AK. Assessment of menopausal symptoms in different transition phases using the Greene Climacteric Scale among rural women of North India. Ann Hum Biol. 2019;46:46&#x2013;55. doi: 10.1080/03014460.2019.1587508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03014460.2019.1587508</ArticleId><ArticleId IdType="pubmed">30822155</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D, Yoshizawa T, Gollschewski S, Atogami F, Courtney M. Relationship between menopausal symptoms and menopausal status in Australian and Japanese women: preliminary analysis. Nurs Health Sci. 2004;6:173&#x2013;180. doi: 10.1111/j.1442-2018.2004.00190.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2018.2004.00190.x</ArticleId><ArticleId IdType="pubmed">15291765</ArticleId></ArticleIdList></Reference><Reference><Citation>Barentsen R, van de Weijer PHM, van Gend S, Foekema H. Climacteric symptoms in a representative Dutch population sample as measured with the Greene Climacteric Scale. Maturitas. 2001;38:123&#x2013;128. doi: 10.1016/S0378-5122(00)00212-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-5122(00)00212-7</ArticleId><ArticleId IdType="pubmed">11306200</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra GD, Kuh D. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ. 2012;344:e402. doi: 10.1136/bmj.e402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e402</ArticleId><ArticleId IdType="pmc">PMC3275131</ArticleId><ArticleId IdType="pubmed">22318435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra B, Hidalgo LA, Chedraui PA. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale. Maturitas. 2005;51:236&#x2013;245. doi: 10.1016/j.maturitas.2004.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2004.08.003</ArticleId><ArticleId IdType="pubmed">15978967</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer RD, Hodis HN, Lobo RA, Allison MA. Hormone replacement therapy &#x2013; where are we now? Climacteric. 2021;24:3&#x2013;10. doi: 10.1080/13697137.2020.1851183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13697137.2020.1851183</ArticleId><ArticleId IdType="pubmed">33403881</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med. 2005;118:14&#x2013;24. doi: 10.1016/j.amjmed.2005.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2005.09.031</ArticleId><ArticleId IdType="pubmed">16414323</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick CA, Brennan A, Hickey M. Managing vasomotor symptoms effectively without hormones. Climacteric. 2020;23:532&#x2013;538. doi: 10.1080/13697137.2020.1789093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13697137.2020.1789093</ArticleId><ArticleId IdType="pubmed">32696683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in &#x201c;long COVID&#x201d;: rationale, physiology and management strategies. Clin Med (Lond) 2021;21:e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlow DH, Cardozo LD, Francis RM, Griffin M, Hart DM, Stephens E, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol. 1997;104:87&#x2013;91. doi: 10.1111/j.1471-0528.1997.tb10655.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.1997.tb10655.x</ArticleId><ArticleId IdType="pubmed">8988703</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlow DH, Samsioe G, Van Geelen JM. A study of European womens&#x2019; experience of the problems of urogenital ageing and its management. Maturitas. 1997;27:239&#x2013;247. doi: 10.1016/S0378-5122(97)00047-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-5122(97)00047-9</ArticleId><ArticleId IdType="pubmed">9288696</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser R, Dimitrakakis C. Testosterone therapy in women: myths and misconceptions. Maturitas. 2013;74:230&#x2013;234. doi: 10.1016/j.maturitas.2013.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2013.01.003</ArticleId><ArticleId IdType="pubmed">23380529</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al. Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. EClinicalmedicine. 2022;53 doi: 10.1016/j.eclinm.2022.101651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType="pmc">PMC9482331</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalmedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise LA, Krieger N, Zierler S, Harlow BL. Lifetime socioeconomic position in relation to onset of perimenopause. J Epidemiol Community Health. 2002;56:851&#x2013;860. doi: 10.1136/jech.56.11.851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.56.11.851</ArticleId><ArticleId IdType="pmc">PMC1732042</ArticleId><ArticleId IdType="pubmed">12388578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor DA, Ebrahim S, Smith GD. The association of socio-economic position across the life course and age at menopause: the British Women's Heart and Health Study. BJOG. 2003;110:1078&#x2013;1087. doi: 10.1016/S1470-0328(03)02519-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-0328(03)02519-9</ArticleId><ArticleId IdType="pubmed">14664879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillman S, Shantikumar S, Ridha A, Todkill D, Dale J. Socioeconomic status and HRT prescribing: a study of practice-level data in England. Br J Gen Pract. 2020;70:e772&#x2013;e777. doi: 10.3399/bjgp20X713045.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp20X713045</ArticleId><ArticleId IdType="pmc">PMC7523922</ArticleId><ArticleId IdType="pubmed">32988956</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Najjar MAA, Al-alwany RR, Al-Rshoud FM, Abu-Farha RK, Zawiah M. Menstrual changes following COVID-19 infection: a cross-sectional study from Jordan and Iraq. PLoS One. 2022;17 doi: 10.1371/journal.pone.0270537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270537</ArticleId><ArticleId IdType="pmc">PMC9242447</ArticleId><ArticleId IdType="pubmed">35767537</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozimek N, Velez K, Anvari H, Butler L, Goldman KN, Woitowich NC. Impact of stress on menstrual cyclicity during the coronavirus disease 2019 pandemic: a survey study. J Womens Health (Larchmt) 2022;31:84&#x2013;90. doi: 10.1089/jwh.2021.0158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0158</ArticleId><ArticleId IdType="pubmed">34582731</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SM, Shilen A, Heslin KM, Ishimwe P, Allen AM, Jacobs ET, et al. SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. Am J Obstet Gynecol. 2022;226:270&#x2013;273. doi: 10.1016/j.ajog.2021.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.09.016</ArticleId><ArticleId IdType="pmc">PMC8452349</ArticleId><ArticleId IdType="pubmed">34555320</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagan&#xe0; AS, Veronesi G, Ghezzi F, Ferrario MM, Cromi A, Bizzarri M, et al. Evaluation of menstrual irregularities after COVID-19 vaccination: results of the MECOVAC survey. Open Med (Wars) 2022;17:475&#x2013;484. doi: 10.1515/med-2022-0452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/med-2022-0452</ArticleId><ArticleId IdType="pmc">PMC8919838</ArticleId><ArticleId IdType="pubmed">35350834</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady E, Nielsen MW, Andersen JP, Oertelt-Prigione S. Lack of consideration of sex and gender in COVID-19 clinical studies. Nat Commun. 2021;12:4015. doi: 10.1038/s41467-021-24265-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24265-8</ArticleId><ArticleId IdType="pmc">PMC8260641</ArticleId><ArticleId IdType="pubmed">34230477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>